Shop

Showing 929–944 of 1289 results

Article: P.01 A LUNG CANCER-DERIVED CRAF MUTATION IS ERK PATHWAY ACTIVATING AND PREDICTS SENSITIVITY TO COMBINED TYPE II RAF AND MEK INHIBITION
€3.03 Add to cart
Article: P.01 Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer (NSCLC) cells
€3.03 Add to cart
Article: P.02 Polymorphisms in the Von Hippel Lindau gene are associated with poor overall survival in metastatic clear-cell renal cell carcinoma patients treated with VEGFR tyrosine kinase inhibitors
€3.03 Add to cart
Article: P.02 THE ROLE OF TOPOISOMERASE II-A (TOPO IIA) AS A PREDICTIVE FACTOR FOR RESPONSE TO NEOADJUVANT ANTHRACYCLINES BASED CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER
€3.03 Add to cart
Article: P.03 Selective internal radiotherapy: a 5-year single-center experience
€3.03 Add to cart
Article: P.03 THE TRITON CLINICAL TRIAL PROGRAMME: EVALUATION OF THE POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR RUCAPARIB IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) ASSOCIATED WITH HOMOLOGOUS RECOMBINATION DEFICIENCY
€3.03 Add to cart
Article: P.04 ENDOTHELIAL CELL METABOLISM BLOCKADE TO INDUCE TUMOR VESSEL NORMALIZATION AND IMPROVE CURRENT IMMUNOTHERAPY
€3.03 Add to cart
Article: P.04 Osteonecrosis of the Jaw Incidence in Patients Treated Sequentially with Bisphosphonates and Denosumab
€3.03 Add to cart
Article: P.05 Incidence of osteonecrosis of the jaw in patients both treated with bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors
€3.03 Add to cart
Article: P.05 LONG-TERM CLINICAL OUTCOME AND SURVIVORSHIP ISSUES OF HIGH GRADE BONE SARCOMAS
€3.03 Add to cart
Article: P.06 A Nursing Intervention for Reducing Symptom Burden during Chemotherapy (CHEMO-SUPPORT): Results of a Quasi-Experimental Study
€3.03 Add to cart
Article: P.06 THE IMPACT OF NETWERK ON THE MULTIDISCIPLINARY TUMOR BOARDS
€3.03 Add to cart
Article: P.07 EXCELLENT SURVIVAL OUTCOMES FOR NET PATIENTS TREATED WITHIN NETWERK, A COLLABORATIVE ENETS CENTER OF EXCELLENCE
€3.03 Add to cart
Article: P.07 The role of CD70 in oropharyngeal squamous cell carcinoma and effect on survival
€3.03 Add to cart
Article: P.08 A prospective study on the impact of a NET specific multidisciplinary tumor board on individual treatment plans
€3.03 Add to cart
Article: P.08 AUTOIMMUNE POLYARTHRITIS: A RARE COMPLICATION OF RENAL CLEAR CELL CARCINOMA ON IMMUNOTHERAPY
€3.03 Add to cart

Article: P.01 A LUNG CANCER-DERIVED CRAF MUTATION IS ERK PATHWAY ACTIVATING AND PREDICTS SENSITIVITY TO COMBINED TYPE II RAF AND MEK INHIBITION

Article: P.01 Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer (NSCLC) cells

Article: P.02 Polymorphisms in the Von Hippel Lindau gene are associated with poor overall survival in metastatic clear-cell renal cell carcinoma patients treated with VEGFR tyrosine kinase inhibitors

Article: P.02 THE ROLE OF TOPOISOMERASE II-A (TOPO IIA) AS A PREDICTIVE FACTOR FOR RESPONSE TO NEOADJUVANT ANTHRACYCLINES BASED CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER

Article: P.03 Selective internal radiotherapy: a 5-year single-center experience

Article: P.03 THE TRITON CLINICAL TRIAL PROGRAMME: EVALUATION OF THE POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR RUCAPARIB IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) ASSOCIATED WITH HOMOLOGOUS RECOMBINATION DEFICIENCY

Article: P.04 ENDOTHELIAL CELL METABOLISM BLOCKADE TO INDUCE TUMOR VESSEL NORMALIZATION AND IMPROVE CURRENT IMMUNOTHERAPY

Article: P.04 Osteonecrosis of the Jaw Incidence in Patients Treated Sequentially with Bisphosphonates and Denosumab

Article: P.05 Incidence of osteonecrosis of the jaw in patients both treated with bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors

Article: P.05 LONG-TERM CLINICAL OUTCOME AND SURVIVORSHIP ISSUES OF HIGH GRADE BONE SARCOMAS

Article: P.06 A Nursing Intervention for Reducing Symptom Burden during Chemotherapy (CHEMO-SUPPORT): Results of a Quasi-Experimental Study

Article: P.06 THE IMPACT OF NETWERK ON THE MULTIDISCIPLINARY TUMOR BOARDS

Article: P.07 EXCELLENT SURVIVAL OUTCOMES FOR NET PATIENTS TREATED WITHIN NETWERK, A COLLABORATIVE ENETS CENTER OF EXCELLENCE

Article: P.07 The role of CD70 in oropharyngeal squamous cell carcinoma and effect on survival

Article: P.08 A prospective study on the impact of a NET specific multidisciplinary tumor board on individual treatment plans

Article: P.08 AUTOIMMUNE POLYARTHRITIS: A RARE COMPLICATION OF RENAL CLEAR CELL CARCINOMA ON IMMUNOTHERAPY